International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

…, TA Lee, KB Weiss, RL Jensen, GB Marks, A Gulsvik… - The Lancet, 2007 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity
and mortality worldwide, and accurate estimates of the prevalence of this disease are …

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

…, R Pauwels, J Vestbo, P Jones, N Pride, A Gulsvik… - The Lancet, 2003 - thelancet.com
Background Inhaled longacting β 2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled corticosteroids …

[HTML][HTML] A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci

…, AC Need, S Feng, CP Hersh, P Bakke, A Gulsvik… - PLoS …, 2009 - journals.plos.org
There is considerable variability in the susceptibility of smokers to develop chronic obstructive
pulmonary disease (COPD). The only known genetic risk factor is severe deficiency of α 1 -…

Meta-analysis and imputation refines the association of 15q25 with smoking quantity

…, P McGuffin, R Day, K Matthews, P Bakke, A Gulsvik… - Nature …, 2010 - nature.com
Smoking is a leading global cause of disease and mortality 1 . We established the Oxford-GlaxoSmithKline
study (Ox-GSK) to perform a genome-wide meta-analysis of SNP association …

Variants in FAM13A are associated with chronic obstructive pulmonary disease

…, R Tal-Singer, DA Lomas, P Bakke, A Gulsvik… - Nature …, 2010 - nature.com
We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD)
in three population cohorts, including 2,940 cases and 1,380 controls who were …

Gender differences in COPD: are women more susceptible to smoking effects than men?

IC Sørheim, A Johannessen, A Gulsvik, PS Bakke… - Thorax, 2010 - thorax.bmj.com
Background The number of female smokers developing chronic obstructive pulmonary disease
(COPD) is rapidly increasing, but whether or not there exists a differential susceptibility …

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis

…, DA Lomas, P Bakke, A Gulsvik… - The lancet Respiratory …, 2014 - thelancet.com
Background The genetic risk factors for susceptibility to chronic obstructive pulmonary disease
(COPD) are still largely unknown. Additional genetic variants are likely to be identified by …

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

…, RG Barr, D Sparrow, AA Litonjua, P Bakke, A Gulsvik… - Nature …, 2017 - nature.com
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide 1 .
We performed a genetic association study in 15,256 cases and 47,936 controls, with …

New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries

…, F Dudbridge, R Ewert, C Gieger, A Gulsvik… - Nature …, 2019 - nature.com
Reduced lung function predicts mortality and is key to the diagnosis of chronic obstructive
pulmonary disease (COPD). In a genome-wide association study in 400,102 individuals of …

Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study

…, P Burney, PL Enright, A Gulsvik… - European …, 2009 - Eur Respiratory Soc
Published guidelines recommend spirometry to accurately diagnose chronic obstructive
pulmonary disease (COPD). However, even spirometry-based COPD prevalence estimates can …